Literature DB >> 17714434

Vps22/EAP30 in ESCRT-II mediates endosomal sorting of growth factor and chemokine receptors destined for lysosomal degradation.

Lene Malerød1, Susanne Stuffers, Andreas Brech, Harald Stenmark.   

Abstract

The ubiquitin-binding protein Hrs and endosomal sorting complex required for transport (ESCRT)-I and ESCRT-III are involved in sorting endocytosed and ubiquitinated receptors to lysosomes for degradation and efficient termination of signaling. In this study, we have investigated the role of the ESCRT-II subunit Vps22/EAP30 in degradative protein sorting of ubiquitinated receptors. Vps22 transiently expressed in HeLa cells was detected in endosomes containing endocytosed epidermal growth factor receptors (EGFRs) as well as Hrs and ESCRT-I and ESCRT-III. Depletion of Vps22 by small interfering RNA, which was accompanied by decreased levels of other ESCRT-II subunits, greatly reduced degradation of EGFR and its ligand EGF as well as the chemokine receptor CXCR4. EGFR accumulated on the limiting membranes of early endosomes and aberrantly small multivesicular bodies in Vps22-depleted cells. Phosphorylation and nuclear translocation of extracellular-signal-regulated kinase1/2 downstream of the EGF-activated receptor were sustained by depletion of Hrs or the ESCRT-I subunit Tsg101. In contrast, this was not the case when Vps22 was depleted. These results indicate an important role for Vps22 in ligand-induced EGFR and CXCR4 turnover and suggest that termination of EGF signaling occurs prior to ESCRT-II engagement.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17714434     DOI: 10.1111/j.1600-0854.2007.00630.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  57 in total

Review 1.  Shaping development with ESCRTs.

Authors:  Tor Erik Rusten; Thomas Vaccari; Harald Stenmark
Journal:  Nat Cell Biol       Date:  2011-12-22       Impact factor: 28.824

Review 2.  Ubiquitination of G protein-coupled receptors: functional implications and drug discovery.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Mol Pharmacol       Date:  2012-06-14       Impact factor: 4.436

Review 3.  Atypical regulation of G protein-coupled receptor intracellular trafficking by ubiquitination.

Authors:  Michael R Dores; JoAnn Trejo
Journal:  Curr Opin Cell Biol       Date:  2013-12-07       Impact factor: 8.382

4.  No strings attached: the ESCRT machinery in viral budding and cytokinesis.

Authors:  Bethan McDonald; Juan Martin-Serrano
Journal:  J Cell Sci       Date:  2009-07-01       Impact factor: 5.285

Review 5.  The ESCRT machinery: from the plasma membrane to endosomes and back again.

Authors:  Amber L Schuh; Anjon Audhya
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-01-24       Impact factor: 8.250

Review 6.  Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications.

Authors:  Sweta Rani; Aideen E Ryan; Matthew D Griffin; Thomas Ritter
Journal:  Mol Ther       Date:  2015-03-19       Impact factor: 11.454

7.  Comparative Analysis of Transmembrane Regulators of the Filamentous Growth Mitogen-Activated Protein Kinase Pathway Uncovers Functional and Regulatory Differences.

Authors:  Hema Adhikari; Lauren M Caccamise; Tanaya Pande; Paul J Cullen
Journal:  Eukaryot Cell       Date:  2015-06-26

Review 8.  The multiple layers of ubiquitin-dependent cell cycle control.

Authors:  Katherine Wickliffe; Adam Williamson; Lingyan Jin; Michael Rape
Journal:  Chem Rev       Date:  2009-04       Impact factor: 60.622

Review 9.  Membrane fission reactions of the mammalian ESCRT pathway.

Authors:  John McCullough; Leremy A Colf; Wesley I Sundquist
Journal:  Annu Rev Biochem       Date:  2013-03-18       Impact factor: 23.643

10.  Genetic interactions between the Drosophila tumor suppressor gene ept and the stat92E transcription factor.

Authors:  M Melissa Gilbert; Carolyn K Beam; Brian S Robinson; Kenneth H Moberg
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.